journal article·2018-12

Kinetic and thermodynamic assessment on isoniazid/montmorillonite adsorption

Esperanza Carazo, Ana Borrego-Sánchez, Rita Sánchez-Espejo, Fátima García-Villén, Pilar Cerezo, Carola Aguzzi, César Viseras

Publisher page

Abstract

Abstract The properties of montmorillonite (Mt) as a natural nanocarrier of drugs have been fully reported. Isoniazid (INH), a first-line tuberculostatic drug, was intercalated into this inorganic matrix and the equilibrium and thermodynamic aspects of the adsorption process were evaluated. Adsorption experiments were performed at different times and temperatures in aqueous medium. The overall adsorption process was the result of two simple processes: INH adsorption on the activated sites of Mt. followed by a slight precipitation phase of INH molecules over the adsorbed monolayer. Formation of the nanohybrid was spontaneous, exothermic and exoentropic, obtaining an increase in the thermodynamic stability of the system. The hybrid material (Mt-INH) was successfully prepared with high drug loading. Solid state characterization of the pure materials and the resulting nanohybrid was carried out. Fourier transform infrared spectroscopy (FTIR), thermogravimetry (TGA), differential scanning calorimetry (DSC), surface charge, X-ray powder diffraction (XRPD) and high resolution transmission electron microscopy (HRTEM) coupled with energy dispersive spectroscopy (XEDS) and elemental X-ray maps served to correctly resolve the structure of the nanohybrid and to assess the nature and degree of the drug-clay interactions.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Clay minerals and soil interactions · Layered Double Hydroxides Synthesis and Applications · Polymer Nanocomposites and Properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (48)

Show source-provided references
1. Use of clays as drug delivery systems: possibilities and limitations10.1016/j.clay.2006.06.015 ↗
2. Chitosan–silicate biocomposites to be used in modified drug release of 5-aminosalicylic acid (5-ASA)10.1016/j.clay.2010.07.011 ↗
3. Solid state characterisation of silver sulfadiazine loaded on montmorillonite/chitosan nanocomposite for wound healing. Colloids surf10.1016/j.colsurfb.2013.08.043 ↗
4. FT-IR and FT-Raman spectroscopic studies of adsorption of isoniazid by montmorillonite and saponite Vib
5. Promethazine–montmorillonite inclusion complex to enhance drug photostability10.1021/la5033898 ↗
6. Interpenetrating polymer network blend microspheres of chitosan and hydroxyethyl cellulose for controlled release of isoniazid10.1016/j.ijbiomac.2010.05.003 ↗
7. Adsorption of pharmaceuticals in water using Fe3O4 coated polymer clay composite10.1016/j.micromeso.2016.06.033 ↗
8. Preparation and evaluation of the effect of particle size on the properties of chitosan-montmorillonite nanoparticles loaded with isoniazid10.1039/c2ra20702h ↗
9. Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles10.1016/j.ijpharm.2012.11.042 ↗
10. Drug-drug interaction studies on first-line anti-tuberculosis drugs10.1080/10837450500299982 ↗
11. Biopharmaceutical improvement of praziquantel by interaction with montmorillonite and sepiolite10.1016/j.clay.2017.12.024 ↗
12. A thermodynamic description of the adsorption of simple water-soluble peptoids to silica10.1021/acs.langmuir.6b02804 ↗
13. Use of clays as Nanocarriers of first-line Tuberculostatic drugs10.2174/1567201813666160714160727 ↗
14. Assessment of halloysite nanotubes as vehicles of isoniazid10.1016/j.colsurfb.2017.09.036 ↗
15. Adsorption and characterization of palygorskite-isoniazid nanohybrids10.1016/j.clay.2017.12.027 ↗
16. Extreme thermal shielding effects in nanopaper based on multilayers of aligned clay nanoplatelets in cellulose nanofiber matrix10.1002/admi.201600551 ↗
17. A physiologically based pharmacokinetic model of isoniazid and its application in individualizing tuberculosis chemotherapy10.1128/AAC.00508-16 ↗
18. Montmorillonite-lipid hybrid carriers for ionizable and neutral poorly water-soluble drugs: formulation, characterization and in vitro lipolysis studies10.1016/j.ijpharm.2017.04.063 ↗
19. Extended-release of chlorpromazine intercalated into montmorillonite clays10.1016/j.micromeso.2018.03.017 ↗
20. A general treatment and classification of the solute adsorption isotherm10.1016/0021-9797(74)90252-5 ↗
21. Laponite functionalized with biuret and melamine–application to adsorption of antibiotic trimethoprim10.1016/j.micromeso.2017.06.047 ↗
22. Greene-Kelly · 1957 · 140
23. Nanocontainers for self-healing coatings10.1002/admi.201600318 ↗
24. Exceptional flame resistance and gas barrier with thick multilayer nanobrick wall thin films10.1002/admi.201500214 ↗
25. Description of sorption data with isotherm equations10.1016/S0016-7061(00)00071-9 ↗
26. Fabrication of adsorbents with thermocontrolled molecular gates for both selective adsorption and efficient regeneration10.1002/admi.201500829 ↗
27. Fabrication of magnetic silica-pillared clay (SPC) nanocomposites with ordered interlayer mesoporous structure for controlled drug release10.1016/j.micromeso.2013.10.020 ↗
28. Advantageous delivery of nifedipine from inorganic materials showing increased solubility and biocompatibility10.1016/j.micromeso.2013.09.021 ↗
29. Mixed protein/hexane adsorption layers formed at the surface of protein solution drops surrounded by hexane vapor10.1002/admi.201600031 ↗
30. Recent therapeutic approaches for the management of tuberculosis: challenges and opportunities10.1016/j.biopha.2018.01.115 ↗
31. X-powder, a software package for powder X-ray diffraction analysis
32. In vitro biocompatibility and mucoadhesion of montmorillonite chitosan nanocomposite: a new drug delivery10.1016/j.clay.2011.11.006 ↗
33. Intestinal permeability of oxytetracycline from chitosan-montmorillonite nanocomposites10.1016/j.colsurfb.2013.11.009 ↗
34. Montmorillonite–chitosan–silver sulfadiazine nanocomposites for topical treatment of chronic skin lesions: in vitro biocompatibility, antibacterial efficacy and gap closure cell motility properties10.1016/j.carbpol.2013.10.029 ↗
35. Clay minerals for tissue regeneration, repair, and engineering
36. Study on crosslinked gelatin–montmorillonite nanoparticles for controlled drug delivery applications10.1007/s10853-015-9287-3 ↗
37. Kinetic and conformational insights of protein adsorption onto montmorillonite revealed using in situ ATR-FTIR/2D-COS10.1021/acs.langmuir.6b00786 ↗
38. Molecular ordering at the interface between liquid water and rutile TiO2 (110). Adv. Mater
39. Investigation of the adsorption of amphipathic macroRAFT agents onto montmorillonite clay10.1021/acs.langmuir.7b01882 ↗
40. Carrier particle design for stabilization and isolation of drug nanoparticlesInt
41. Application of a single model to study the adsorption equilibrium of prednisolone on six carbonaceous materials10.1006/jcis.2002.8329 ↗
42. A comparative study of the adsorption equilibrium of progesterone by a carbon black and a commercial activated carbon10.1016/j.apsusc.2006.11.047 ↗
43. Mechanochemically synthesized poly(o-toluidine)-intercalated montmorillonite nanocomposites as antituberculosis drug carriers10.1080/00914037.2017.1320658 ↗
44. Equilibrium and kinetics of 5-aminosalicylic acid adsorption by halloysiteMicroporous10.1016/j.micromeso.2007.03.033 ↗
45. WHO · 2017
46. WHO · 2017
47. Functionalized 2D clay derivative: hybrid nanosheets with unique lead sorption behaviors and interface structure10.1002/admi.201700934 ↗
48. Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies10.1016/S2213-2600(15)00063-6 ↗